Effectiveness of Laser Therapy on Proximal Hamstring Tendinopathy

Sponsor
King Saud University (Other)
Overall Status
Completed
CT.gov ID
NCT05100394
Collaborator
(none)
36
1
2
5.6
6.4

Study Details

Study Description

Brief Summary

Proximal hamstring tendinopathy (PHT) is tendinopathy of the semimembranosus and/or biceps femoris/semitendinosus complex. Previous studies have shown the efficacy of laser therapy in the treatment of tendinopathy. To the best of the investigator's knowledge, no study has compared the effects of high-power LASER therapy with conventional physiotherapy programs in proximal hamstring tendinopathy patients. Therefore, this study aimed to assess the effects of high-power laser therapy on pain and muscle power in proximal hamstring tendinopathy patients.

Condition or Disease Intervention/Treatment Phase
  • Radiation: Laser Therapy
  • Other: Ultrasound + Moist Heat pack + Exercises
N/A

Detailed Description

2 arms comparative pretest-posttest experimental research design with random allocation of subjects into groups (experimental and control group) using the lottery method. A total of thirty-six participants aged between 18-35 (mean age) years, were recruited in the present study. The selected participants were randomly allocated into experimental and control groups using the lottery method and website randomization.com with eighteen participants in each group. The participants and outcome assessor were kept blinded to the allocation. In the experimental group, the high-power laser was given whereas in the control group conventional physiotherapy treatment was given for 4 weeks. Conventional physiotherapy treatment included the US, moist heat pack, and home exercises. Home exercises include nordic hamstring exercises - 2 sets of 5 repetitions, 3 days/week for 3 weeks.

Study Design

Study Type:
Interventional
Actual Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two-arm parallel-groupsTwo-arm parallel-groups
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Participants and outcome assessor was unaware of allocation into experimental or control groups.
Primary Purpose:
Treatment
Official Title:
Effectiveness of High Power Laser Therapy on Pain and Isokinetic Power in Athletes With Proximal Hamstring Tendinopathy: a Randomized Controlled Trial
Actual Study Start Date :
Apr 5, 2021
Actual Primary Completion Date :
Aug 27, 2021
Actual Study Completion Date :
Sep 23, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental Group

High Power laser therapy was provided.

Radiation: Laser Therapy
Therapeutic laser therapy was applied.

Active Comparator: Control Group

Conventional physiotherapy was applied including moist heat packs, US, and eccentric hamstring exercises.

Other: Ultrasound + Moist Heat pack + Exercises
Ultrasound therapy, a moist heat pack, and a home exercise program were given.

Outcome Measures

Primary Outcome Measures

  1. Numerical Pain Rating Scale [3 weeks.]

    On a scale of 0-10, patients rate their current pain level. Higher scores mean worse outcome.

  2. Isokinetic peak torque [3 weeks.]

    Isokinetic muscle power was measured.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Athletes

  • pain located deep in the buttock/posterior thigh region

  • tenderness of ischial tuberosity

  • hamstring muscle tightness.

Exclusion Criteria:
  • Recent trauma to the posterior thigh

  • Musculoskeletal disorder of ipsilateral lower extremity

  • taking pain medication daily

  • hypertension, malignancy, autoimmune disease, phlebitis, blood disorder.

Contacts and Locations

Locations

Site City State Country Postal Code
1 King Saud University Riyadh Saudi Arabia 11433

Sponsors and Collaborators

  • King Saud University

Investigators

  • Principal Investigator: Masood Khan, MPTh, King Saud University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Masood Khan, Researcher, King Saud University
ClinicalTrials.gov Identifier:
NCT05100394
Other Study ID Numbers:
  • RRC-2021-07
First Posted:
Oct 29, 2021
Last Update Posted:
Nov 8, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Masood Khan, Researcher, King Saud University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 8, 2021